ATE223055T1 - Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit - Google Patents

Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit

Info

Publication number
ATE223055T1
ATE223055T1 AT96912401T AT96912401T ATE223055T1 AT E223055 T1 ATE223055 T1 AT E223055T1 AT 96912401 T AT96912401 T AT 96912401T AT 96912401 T AT96912401 T AT 96912401T AT E223055 T1 ATE223055 T1 AT E223055T1
Authority
AT
Austria
Prior art keywords
extracellular fluid
diagnosing chlamydia
biological extracellular
chlamydia
biological
Prior art date
Application number
AT96912401T
Other languages
English (en)
Inventor
Alex B Macdonald
Stuart Elizabeth Sutton
Ling-Ling An
Myron D Whipkey
Original Assignee
Animal House Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Animal House Inc filed Critical Animal House Inc
Application granted granted Critical
Publication of ATE223055T1 publication Critical patent/ATE223055T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4233—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-bacterial Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • External Artificial Organs (AREA)
AT96912401T 1995-03-17 1996-02-28 Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit ATE223055T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/406,113 US5716793A (en) 1993-03-19 1995-03-17 Method for diagnosing a patient for chlamydia
PCT/US1996/002617 WO1996029604A1 (en) 1995-03-17 1996-02-28 Method for diagnosing a patient for chlamydia

Publications (1)

Publication Number Publication Date
ATE223055T1 true ATE223055T1 (de) 2002-09-15

Family

ID=23606592

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912401T ATE223055T1 (de) 1995-03-17 1996-02-28 Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit

Country Status (8)

Country Link
US (1) US5716793A (de)
EP (1) EP0827591B1 (de)
CN (1) CN1163754C (de)
AT (1) ATE223055T1 (de)
AU (1) AU703656B2 (de)
DE (1) DE69623276T2 (de)
NZ (1) NZ306622A (de)
WO (1) WO1996029604A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511805B1 (en) * 1996-03-15 2003-01-28 The Penn State Research Foundation Methods for detecting papillomavirus DNA in blood plasma and serum
EP0929694A4 (de) 1996-03-15 2002-05-02 Penn State Res Found Nachweis von extrazellulärer tumor-assoziierter nukleinsäuren im blutplasma oder -serum mittels eines nukleinsäure-amplifizierungsverfahren
US8048629B2 (en) * 1996-03-15 2011-11-01 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
US20010048927A1 (en) * 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
JP2003530358A (ja) * 2000-04-06 2003-10-14 ユニバーシティー オブ マサチューセッツ クラミジア糖脂質ワクチン
GB0130947D0 (en) * 2001-12-24 2002-02-13 Lee Helen Improved sample preparation for the detection of infectious agents
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
EP1743172A2 (de) * 2004-04-16 2007-01-17 University of Massachusetts Nachweis und quantifizierung von intrazellulären pathogenen
US20090317840A1 (en) * 2006-07-27 2009-12-24 Heinrichs Jon H Automated determination of chlamydia infection-forming units

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828981A (en) * 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
US5234817A (en) * 1988-10-07 1993-08-10 Eastman Kodak Company Wash solution containing a cationic surfactant and its use in chlamydial and gonococcal determinations
US5085986A (en) * 1989-06-14 1992-02-04 Eastman Kodak Company Diagnostic test kit and method for determination of chlamydial antigen using a membrane having surface hydroxy groups
US5246831A (en) * 1990-09-21 1993-09-21 Synbiotics Corporation Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies
US5840297A (en) * 1993-03-19 1998-11-24 Johns Hopkins University Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process

Also Published As

Publication number Publication date
CN1163754C (zh) 2004-08-25
EP0827591A1 (de) 1998-03-11
NZ306622A (en) 2000-01-28
EP0827591A4 (de) 1999-04-21
AU5523096A (en) 1996-10-08
CN1184531A (zh) 1998-06-10
EP0827591B1 (de) 2002-08-28
WO1996029604A1 (en) 1996-09-26
DE69623276D1 (de) 2002-10-02
AU703656B2 (en) 1999-04-01
US5716793A (en) 1998-02-10
DE69623276T2 (de) 2003-08-07

Similar Documents

Publication Publication Date Title
ATE98773T1 (de) Verfahren zur optischen analyse.
DE59610431D1 (de) Optochemischer Fluoreszenzsensor sowie ein Verfahren zur Messung der Konzentration zumindest eines Analyten in einer Probe
DE69434867D1 (de) Gerät zur Bestimmung eines Analyten in einer Probe
DE69025199D1 (de) Verfahren zum in vivo-nachweis von knochenresorption
DE69530861D1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
ES2119369T3 (es) Dispositivo sensor para un ensayo sandwich.
ATE31822T1 (de) Testvorrichtung.
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
ATE223055T1 (de) Verfahren zur diagnose von chlamydia in einer biologischen extrazellulären flüssigkeit
DE69124511D1 (de) Verfahren für den nachweis und/oder die bestimmung von hormonen
ATE26187T1 (de) Vorrichtung zum homogenen spezifischen bindungsassay, verfahren zu deren herstellung und analytisches verfahren zur anwendung der vorrichtung.
ATE187251T1 (de) Verfahren zum nachweis der gegenwart einer mykobakterien-spezies und testsatz sowie antikörpes zur verwendung in diesem verfahren
ATE354800T1 (de) Verfahren zum nachweiss von antikörpern in einer probe
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
ATE308752T1 (de) Ein verfahren zum auffinden und/oder quantifizieren eines spezifischen ige-antikörpers in einer flüssigen probe
DE69526056T2 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
ATE249627T1 (de) Vorrichtung und test zur bestimmung eines antigens oder eines antikörpers in einer testprobe
CA2215528A1 (en) Method for diagnosing a patient for chlamydia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties